試題詳解

4. 標靶治療藥物Tyrosine kinase inhibitor, Imatinib, 對下列何種急性淋巴芽細胞白血病(ALL)有效？
(A) B-lineage ALL with t(9;22)
(B) B-lineage ALL with t(4;11)
(C) CD19 positive B-lineage ALL
(D) CD20 positive B-lineage ALL
(E) CD3 positive T-lineage ALL